Toward a Better Understanding of Value in Glaucoma Treatment

Joshua R Ehrlich^{1

2}, Emily M Schehlein¹

Affiliations

¹ Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor.
² Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor.

Comment

Joshua R Ehrlich et al. JAMA Ophthalmol. 2021.

. 2021 Aug 1;139(8):874-875.

doi: 10.1001/jamaophthalmol.2021.1872.

Joshua R Ehrlich^{1

2}, Emily M Schehlein¹

¹ Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor.
² Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor.

No abstract available

Comment on

Development and Validation of a Preference-Based Glaucoma Utility Instrument Using Discrete Choice Experiment.
Fenwick EK, Ozdemir S, Man REK, Baid D, Htoon HM, Gan ATL, Tey ML, Aw AT, Baskaran M, Nongpiur ME, Finkelstein EA, Tey CS, Soon HJT, Sabanayagam C, Sng CCA, Wong TY, Husain R, Perera SA, Lun K, Aung T, Lamoureux EL. Fenwick EK, et al. JAMA Ophthalmol. 2021 Aug 1;139(8):866-874. doi: 10.1001/jamaophthalmol.2021.1874. JAMA Ophthalmol. 2021. PMID: 34165504 Free PMC article.